Head office
Production facility
PHARMAQ AS
Skogmo Industriområde
Industrivegen 50
7863 Overhalla, Norway
Tel:+47 74 28 08 00
Fax:+47 74 28 08 01
Oslo office
PHARMAQ AS
Harbitzalléen 2A, 0275 Oslo,
P.O.Box 267 Skøyen, N-0213 Oslo, Norway
Tel: +47 23 29 85 00
Fax: :+47 23 29 85 01
customer.service@pharmaq.no
-
For animals
For health
For you -
Our solutions
support healthy
growth in
aquaculture -
Supporting our
customers in
ever better ways -
Supporting those
who raise and
care for fish -
We make
aquaculture
progress
PHARMAQ Insight
Not a customer? CONTACT US
Sign up for newsletter
PHARMAQ ACHIEVEMENTS
1987
We launched the first vaccine ever against cold water vibriosis - ”saving” the Norwegian salmon industry and dramatically reduced the use of antibiotics
1991
Introduction of the world’s first oil based fish vaccine offering protection against furunculosis
1996
Our State-of-the-art GMP production facility for fish vaccines opens in Overhalla, Norway
1997
The first six component vaccine ever introduced in Norway. Includes protection against IPNV and winter ulcer.
1998
ALPHA MAX® for bath treatment against salmon lice available in the Norwegian- and the Faroese market
2001
Established office in Puerto Montt, Chile, later to become PHARMAQ AS Chile Ltda.
2002
The first European fish vaccine ever approved by the Canadian authorities
2004
Obtained approval in UK for the first virus vaccine for fish - protection against IPNV and furunculosis
2004
PHARMAQ established 23 July by 'management buy out' of the Aquatic Animal Health business of Alpharma Inc.
2007
Launch of our first generation SRS vaccine in Chile
2008
MA approved for ALPHA JECT micro® 6 in Norway, the first six-component micro dose vaccine available
2008
Sales license for ALPHA JECT® micro 3 in Chile, the first trivalent SRS micro dose vaccine available
2008
PHARMAQ opened office in Vietnam, later to become PHARMAQ Ltd. VN
2008
Acquisition of PHARMAQ by Orkla and Kverva
2009
Extensive field trial of the first Pangasius vaccine started in Vietnam
2010
PHARMAQ’s first ISA vaccine received a provisional marketing authorisation from the Chilean authorities
2011
PHARMAQ officially opened its PHARMAQ Turkey Ltd office in Izmir in May
2011
PHARMAQ signed a long term agreement with Norwegian Institute of Public Health for lease of virus antigen production facilities in Norway
2011
As the first fish vaccine commercially available in Vietnam, ALPHA JECT Panga 1 received a observation license
2012
PHARMAQ Holding acquires Havbruksinstituttet AS, renamed as PHARMAQ Analytiq
2013
Permira acquired PHARMAQ May 2013
2014
PHARMAQ and The Ministry of Agriculture and Rural Development in Vietnam signed agreement of co-operation
2015
PHARMAQ is now part of Zoetis, the world leader in animal health. For more information about our owner, visit www.zoetis.com
2016
PHARMAQ launched our first attenuated live vaccine in Chile against SRS, ALPHA JECT LiVac® SRS
Future
We make aquaculture progress!